These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 31694584)

  • 1. Quality of life assessment in patients with heart failure: validity of the German version of the generic EQ-5D-5L™.
    Boczor S; Daubmann A; Eisele M; Blozik E; Scherer M
    BMC Public Health; 2019 Nov; 19(1):1464. PubMed ID: 31694584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors associated with quality of life in heart failure patients considering the use of the generic EQ-5D-5L™ in primary care: new follow-up results of the observational RECODE-HF study.
    Boczor S; Eisele M; Rakebrandt A; Menzel A; Blozik E; Träder JM; Störk S; Herrmann-Lingen C; Scherer M;
    BMC Fam Pract; 2021 Oct; 22(1):202. PubMed ID: 34645408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation, cross-cultural adaptation, and psychometric validation of the Malay version of the Assessment of Quality of Life-6 Dimensions (Malay-AQoL-6D) instrument among Malaysians living with chronic heart failure.
    Tan YJ; Ong SC; Goh SP; Chen G; Yong VS; Khor WW; Kan YM; Choong YY; Zameram AM; Tan LY; Voo JYH; Lam KK; Yen CH; Wahab MJA; Abdulla ZB
    J Patient Rep Outcomes; 2024 Jul; 8(1):79. PubMed ID: 39052204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure.
    Kontodimopoulos N; Argiriou M; Theakos N; Niakas D
    Eur J Health Econ; 2011 Aug; 12(4):383-91. PubMed ID: 20473544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity and measurement equivalence of EQ-5D-5L questionnaire among heart failure patients in Malaysia: a cohort study.
    Kuan WC; Chee KH; Kasim S; Lim KK; Dujaili JA; Lee KK; Teoh SL
    J Med Econ; 2024; 27(1):607-617. PubMed ID: 38557412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining health-related quality of life in ambulatory adult patients with chronic heart failure: insights from Malaysia using EQ-5D-5L.
    Tan YJ; Ong SC; Yong VS; Khor WW; Pang LJ; Choong YY; Zameram AM; Tan LY; Voo JYH; Lam KK; Yen CH; Wahab MJA; Abdulla ZB
    Qual Life Res; 2024 Aug; 33(8):2181-2195. PubMed ID: 38839679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of the EQ-5D-Y health related quality of life outcome measure in children in the Western Cape, South Africa: psychometric properties, feasibility and usefulness - a longitudinal, analytical study.
    Scott D; Ferguson GD; Jelsma J
    Health Qual Life Outcomes; 2017 Jan; 15(1):12. PubMed ID: 28103872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life assessment in diabetic patients: validity of the creole version of the EQ-5D-5L in Reunion Island.
    Safieddine M; Bruneau L; Soulaimana I; Debussche X; Lafarge S; Falissard B; Ferdynus C; Huiart L
    Front Psychol; 2023; 14():1185316. PubMed ID: 37397299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the EQ-5D in patients with irritable bowel syndrome.
    Bushnell DM; Martin ML; Ricci JF; Bracco A
    Value Health; 2006; 9(2):90-7. PubMed ID: 16626412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.
    Gergely LH; Gáspár K; Brodszky V; Kinyó Á; Szegedi A; Remenyik É; Kiss NF; Bató A; Péntek M; Gulácsi L; Sárdy M; Bánvölgyi A; Wikonkál N; Rencz F
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2584-2592. PubMed ID: 32618022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometrics and validation of the EQ-5D-5L instrument in individuals with ischemic stroke in Lithuania.
    Taroza S; Burkauskas J; Mickuviene N; Kazukauskiene N; Podlipskyte A
    Front Psychol; 2023; 14():1284859. PubMed ID: 38125861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys.
    Martí-Pastor M; Pont A; Ávila M; Garin O; Vilagut G; Forero CG; Pardo Y; Tresserras R; Medina-Bustos A; Garcia-Codina O; Cabasés J; Rajmil L; Alonso J; Ferrer M
    Popul Health Metr; 2018 Aug; 16(1):14. PubMed ID: 30115092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of the EQ-5D-5L for aboriginal Australians: a multi-method study.
    Ribeiro Santiago PH; Haag D; Macedo DM; Garvey G; Smith M; Canfell K; Hedges J; Jamieson L
    Health Qual Life Outcomes; 2021 Mar; 19(1):81. PubMed ID: 33691744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH; Lang BHH; Yu HMS; Lam CLK
    Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of the German version of EQ-5D-Y-5L to measure health-related quality of life in children and adolescents: Identification of response labels and pilot testing].
    Kreimeier S; Greiner W
    Z Evid Fortbild Qual Gesundhwes; 2019 Aug; 144-145():24-34. PubMed ID: 31378708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability, Validity and Responsiveness of the EQ-5D-5L in Assessing and Valuing Health Status in Adolescents and Young Adults with Posttraumatic Stress Disorder: a Randomized Controlled Trail.
    Dams J; Rimane E; Steil R; Renneberg B; Rosner R; König HH
    Psychiatr Q; 2021 Jun; 92(2):459-471. PubMed ID: 32803473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis.
    Tawiah AK; Al Sayah F; Ohinmaa A; Johnson JA
    Health Qual Life Outcomes; 2019 Apr; 17(1):68. PubMed ID: 30995930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis.
    Gualtierotti R; Ingegnoli F; Scalone L; Cortesi P; Bruschi E; Gerosa M; Meroni PL
    Swiss Med Wkly; 2016; 146():w14394. PubMed ID: 28102877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.